Nurix Therapeutics, Inc. NRIX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s operating lease ROU assets?
- Nurix Therapeutics, Inc. (NRIX) reported operating lease ROU assets of $51.66M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Nurix Therapeutics, Inc.'s operating lease ROU assets increased by 96.0% year-over-year, from $26.36M to $51.66M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s operating lease ROU assets has grown at a 30.5% compound annual growth rate (CAGR), from $13.34M to $50.52M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.